Evidence map›Paper›PMID 41618690›Full record

ArticleJournal of veterinary pharmacology and therapeutics2026

Exposure to Subcutaneously Administered Butorphanol in Horses Pre-Treated With Detomidine or Detomidine-Vatinoxan.

Juhana M Honkavaara, Ninja P Karikoski, Laura Palvas, Bruno H Pypendop, Valtteri M Rinne, Marja R Raekallio

Abstract readRandomized Controlled Trial, Veterinary
In one paragraph

Article in Journal of veterinary pharmacology and therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Juhana M HonkavaaraDepartment of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Finland, Helsinki, Finland.ORCID https://orcid.org/0000-0002-8045-3549
Ninja P KarikoskiDepartment of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Finland, Helsinki, Finland.
Laura PalvasDepartment of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Finland, Helsinki, Finland.
Bruno H PypendopDepartment of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, Davis, California, USA.ORCID https://orcid.org/0000-0002-0894-0991
Valtteri M RinneAdmescope (Symeres Finland OY), Oulu, Finland.
Marja R RaekallioDepartment of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Finland, Helsinki, Finland.ORCID https://orcid.org/0000-0002-2653-003X

Funding

The Finnish Veterinary FoundationVetcare
6 · The paper itself

Abstract

The aim of the study was to determine the exposure to subcutaneously administered butorphanol in horses pre-treated with intravenous (IV) detomidine, with or without vatinoxan, a peripherally selective alpha

Indexed as

Adrenergic alpha-2 Receptor AntagonistsAnalgesics, OpioidButorphanolImidazolesQuinolizinesAnimalsArea Under CurveCross-Over StudiesDrug InteractionsFemaleHalf-LifeHorsesInjections, SubcutaneousMaleAdrenergic alpha-2 Receptor AntagonistsAnalgesics, OpioidButorphanoldetomidineImidazolesQuinolizinesvatinoxanbutorphanoldetomidinehorsesubcutaneousvatinoxan

Identifiers

PMID41618690
PMCPMC13159762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.